IRBESARTAN-HYDROCHLOROTHIAZIDE 300-12.5 MG TB

Irbesartan and Hydrochlorothiazide
$0.1698per EA
Low Outlier

Strength

12.5; 300 mg/1; mg/1

NDC

00054025522

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/17/2024

Approval Type

Generic (ANDA)

FDA Application

ANDA090351

On Market Since

10/15/2012

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-23.2%

5Y

-43.6%

All

-66.6%